03:35 PM EDT, 06/29/2026 (MT Newswires) -- Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2%.

The iShares Biotechnology ETF (IBB) rose 0.9%.

In corporate news, Alkermes ( ALKS ) stock has been re-rated following a recent orexin-peer takeout, but upcoming orexin updates risk eroding newly ascribed orexin-related value, BofA Securities said in a research note Monday. BofA downgraded Alkermes ( ALKS ) to underperform from neutral with a price target of $38. Alkermes ( ALKS ) shares were down 4.6%.